IgE to the Mammalian Oligosaccharide Galactose-α-1,3-Galactose Is Associated With Increased Atheroma Volume and Plaques With Unstable Characteristics—Brief Report

OBJECTIVE—Emerging evidence suggests a link between coronary artery disease and type 2 immunity. We sought to test the hypothesis that IgE sensitization to the mammalian oligosaccharide galactose-α-1,3-galactose (α-Gal)—the target allergen of delayed anaphylaxis to red meat—is associated with corona...

Full description

Saved in:
Bibliographic Details
Published inArteriosclerosis, thrombosis, and vascular biology Vol. 38; no. 7; pp. 1665 - 1669
Main Authors Wilson, Jeffrey M., Nguyen, Anh T., Schuyler, Alexander J., Commins, Scott P., Taylor, Angela M., Platts-Mills, Thomas A.E., McNamara, Coleen A.
Format Journal Article
LanguageEnglish
Published United States American Heart Association, Inc 01.07.2018
Lippincott Williams & Wilkins
Subjects
Online AccessGet full text
ISSN1079-5642
1524-4636
1524-4636
DOI10.1161/ATVBAHA.118.311222

Cover

Abstract OBJECTIVE—Emerging evidence suggests a link between coronary artery disease and type 2 immunity. We sought to test the hypothesis that IgE sensitization to the mammalian oligosaccharide galactose-α-1,3-galactose (α-Gal)—the target allergen of delayed anaphylaxis to red meat—is associated with coronary artery disease. APPROACH AND RESULTS—Total IgE and specific IgE to α-Gal were assayed on sera from 118 subjects who presented for cardiac catheterization and underwent intravascular ultrasound. IgE to α-Gal was detected in 26%, and atheroma burden was higher in sensitized subjects (P=0.02). Because α-Gal sensitization relates to an environmental exposure that could be a risk factor for early-onset coronary artery disease (ie, tick bites), we age stratified the cohort. In subjects ≤65 years of age, the strength of the association with atheroma burden was stronger (P<0.001), and plaques in the sensitized group had less stable features based on intravascular ultrasound. To address the specificity of the association with IgE to α-Gal, IgE to inhalants and peanut were assayed and were not associated with coronary artery disease. Total IgE and α-Gal–specific IgE were strongly associated with each other, but the strength of the relationship with atheroma burden was stronger for α-Gal–specific IgE. This association was significant when adjusted for sex, diabetes mellitus, hypertension, statin use, and total IgE (regression coefficient, 12.2; SE, 5.2; P=0.02). CONCLUSIONS—Increased atheroma burden and plaques with more unstable features were associated with IgE to α-Gal—an effect most pronounced in subjects ≤65 years of age. IgE sensitization to α-Gal may represent a novel, and potentially modifiable, risk factor for coronary atherosclerosis.
AbstractList Emerging evidence suggests a link between coronary artery disease and type 2 immunity. We sought to test the hypothesis that IgE sensitization to the mammalian oligosaccharide galactose-α-1,3-galactose (α-Gal)-the target allergen of delayed anaphylaxis to red meat-is associated with coronary artery disease.OBJECTIVEEmerging evidence suggests a link between coronary artery disease and type 2 immunity. We sought to test the hypothesis that IgE sensitization to the mammalian oligosaccharide galactose-α-1,3-galactose (α-Gal)-the target allergen of delayed anaphylaxis to red meat-is associated with coronary artery disease.Total IgE and specific IgE to α-Gal were assayed on sera from 118 subjects who presented for cardiac catheterization and underwent intravascular ultrasound. IgE to α-Gal was detected in 26%, and atheroma burden was higher in sensitized subjects (P=0.02). Because α-Gal sensitization relates to an environmental exposure that could be a risk factor for early-onset coronary artery disease (ie, tick bites), we age stratified the cohort. In subjects ≤65 years of age, the strength of the association with atheroma burden was stronger (P<0.001), and plaques in the sensitized group had less stable features based on intravascular ultrasound. To address the specificity of the association with IgE to α-Gal, IgE to inhalants and peanut were assayed and were not associated with coronary artery disease. Total IgE and α-Gal-specific IgE were strongly associated with each other, but the strength of the relationship with atheroma burden was stronger for α-Gal-specific IgE. This association was significant when adjusted for sex, diabetes mellitus, hypertension, statin use, and total IgE (regression coefficient, 12.2; SE, 5.2; P=0.02).APPROACH AND RESULTSTotal IgE and specific IgE to α-Gal were assayed on sera from 118 subjects who presented for cardiac catheterization and underwent intravascular ultrasound. IgE to α-Gal was detected in 26%, and atheroma burden was higher in sensitized subjects (P=0.02). Because α-Gal sensitization relates to an environmental exposure that could be a risk factor for early-onset coronary artery disease (ie, tick bites), we age stratified the cohort. In subjects ≤65 years of age, the strength of the association with atheroma burden was stronger (P<0.001), and plaques in the sensitized group had less stable features based on intravascular ultrasound. To address the specificity of the association with IgE to α-Gal, IgE to inhalants and peanut were assayed and were not associated with coronary artery disease. Total IgE and α-Gal-specific IgE were strongly associated with each other, but the strength of the relationship with atheroma burden was stronger for α-Gal-specific IgE. This association was significant when adjusted for sex, diabetes mellitus, hypertension, statin use, and total IgE (regression coefficient, 12.2; SE, 5.2; P=0.02).Increased atheroma burden and plaques with more unstable features were associated with IgE to α-Gal-an effect most pronounced in subjects ≤65 years of age. IgE sensitization to α-Gal may represent a novel, and potentially modifiable, risk factor for coronary atherosclerosis.CONCLUSIONSIncreased atheroma burden and plaques with more unstable features were associated with IgE to α-Gal-an effect most pronounced in subjects ≤65 years of age. IgE sensitization to α-Gal may represent a novel, and potentially modifiable, risk factor for coronary atherosclerosis.
Emerging evidence suggests a link between coronary artery disease and type 2 immunity. We sought to test the hypothesis that IgE sensitization to the mammalian oligosaccharide galactose-α-1,3-galactose (α-Gal)-the target allergen of delayed anaphylaxis to red meat-is associated with coronary artery disease. Total IgE and specific IgE to α-Gal were assayed on sera from 118 subjects who presented for cardiac catheterization and underwent intravascular ultrasound. IgE to α-Gal was detected in 26%, and atheroma burden was higher in sensitized subjects ( =0.02). Because α-Gal sensitization relates to an environmental exposure that could be a risk factor for early-onset coronary artery disease (ie, tick bites), we age stratified the cohort. In subjects ≤65 years of age, the strength of the association with atheroma burden was stronger ( <0.001), and plaques in the sensitized group had less stable features based on intravascular ultrasound. To address the specificity of the association with IgE to α-Gal, IgE to inhalants and peanut were assayed and were not associated with coronary artery disease. Total IgE and α-Gal-specific IgE were strongly associated with each other, but the strength of the relationship with atheroma burden was stronger for α-Gal-specific IgE. This association was significant when adjusted for sex, diabetes mellitus, hypertension, statin use, and total IgE (regression coefficient, 12.2; SE, 5.2; =0.02). Increased atheroma burden and plaques with more unstable features were associated with IgE to α-Gal-an effect most pronounced in subjects ≤65 years of age. IgE sensitization to α-Gal may represent a novel, and potentially modifiable, risk factor for coronary atherosclerosis.
OBJECTIVE—Emerging evidence suggests a link between coronary artery disease and type 2 immunity. We sought to test the hypothesis that IgE sensitization to the mammalian oligosaccharide galactose-α-1,3-galactose (α-Gal)—the target allergen of delayed anaphylaxis to red meat—is associated with coronary artery disease. APPROACH AND RESULTS—Total IgE and specific IgE to α-Gal were assayed on sera from 118 subjects who presented for cardiac catheterization and underwent intravascular ultrasound. IgE to α-Gal was detected in 26%, and atheroma burden was higher in sensitized subjects (P=0.02). Because α-Gal sensitization relates to an environmental exposure that could be a risk factor for early-onset coronary artery disease (ie, tick bites), we age stratified the cohort. In subjects ≤65 years of age, the strength of the association with atheroma burden was stronger (P<0.001), and plaques in the sensitized group had less stable features based on intravascular ultrasound. To address the specificity of the association with IgE to α-Gal, IgE to inhalants and peanut were assayed and were not associated with coronary artery disease. Total IgE and α-Gal–specific IgE were strongly associated with each other, but the strength of the relationship with atheroma burden was stronger for α-Gal–specific IgE. This association was significant when adjusted for sex, diabetes mellitus, hypertension, statin use, and total IgE (regression coefficient, 12.2; SE, 5.2; P=0.02). CONCLUSIONS—Increased atheroma burden and plaques with more unstable features were associated with IgE to α-Gal—an effect most pronounced in subjects ≤65 years of age. IgE sensitization to α-Gal may represent a novel, and potentially modifiable, risk factor for coronary atherosclerosis.
Supplemental Digital Content is available in the text.
Author Nguyen, Anh T.
Taylor, Angela M.
Platts-Mills, Thomas A.E.
Schuyler, Alexander J.
McNamara, Coleen A.
Commins, Scott P.
Wilson, Jeffrey M.
AuthorAffiliation From the Division of Allergy and Immunology (J.M.W., A.J.S., T.A.E.P.-M.) Division of Cardiology, Robert M. Berne Cardiovascular Center (A.T.N., A.M.T., C.A.M.), University of Virginia, Charlottesville Division of Rheumatology, Allergy, and Immunology, University of North Carolina, Chapel Hill (S.P.C.)
AuthorAffiliation_xml – name: From the Division of Allergy and Immunology (J.M.W., A.J.S., T.A.E.P.-M.) Division of Cardiology, Robert M. Berne Cardiovascular Center (A.T.N., A.M.T., C.A.M.), University of Virginia, Charlottesville Division of Rheumatology, Allergy, and Immunology, University of North Carolina, Chapel Hill (S.P.C.)
Author_xml – sequence: 1
  givenname: Jeffrey
  surname: Wilson
  middlename: M.
  fullname: Wilson, Jeffrey M.
  organization: From the Division of Allergy and Immunology (J.M.W., A.J.S., T.A.E.P.-M.) Division of Cardiology, Robert M. Berne Cardiovascular Center (A.T.N., A.M.T., C.A.M.), University of Virginia, Charlottesville Division of Rheumatology, Allergy, and Immunology, University of North Carolina, Chapel Hill (S.P.C.)
– sequence: 2
  givenname: Anh
  surname: Nguyen
  middlename: T.
  fullname: Nguyen, Anh T.
– sequence: 3
  givenname: Alexander
  surname: Schuyler
  middlename: J.
  fullname: Schuyler, Alexander J.
– sequence: 4
  givenname: Scott
  surname: Commins
  middlename: P.
  fullname: Commins, Scott P.
– sequence: 5
  givenname: Angela
  surname: Taylor
  middlename: M.
  fullname: Taylor, Angela M.
– sequence: 6
  givenname: Thomas
  surname: Platts-Mills
  middlename: A.E.
  fullname: Platts-Mills, Thomas A.E.
– sequence: 7
  givenname: Coleen
  surname: McNamara
  middlename: A.
  fullname: McNamara, Coleen A.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29903734$$D View this record in MEDLINE/PubMed
BookMark eNp9Ustu1DAUjVARfcAPsEBesiDFrzjJBikdlXakoiLUlmV0x7mZGJy4tT1U7PgIfoEP4Ef4CL4Ej2YYAQsWln3sc8711T2H2d7kJsyyp4weM6bYy-bq5qQ5bxKojgVjnPMH2QEruMylEmovnWlZ54WSfD87DOEDpVRyTh9l-7yuqSiFPMi-zZenJDoSByRvYBzBGpjIpTVLF0DrAbzpkJyBBR1dwPzH95y9EPnugswDaUJw2kDEjrw3cSDzSXuEkGCTbL0bgdw4uxqRwNSRtxbuVhg21OspRFhYJLNUKTmiNyEaHX5--XriDfbkHd46Hx9nD3uwAZ9s96Ps-vXp1ew8v7g8m8-ai1wLldougQvR933Jy6KSXYW9QomoesXqBcgCCya6vuh5haVWmheSYi1BLDSqolIgjrJXG9_b1WLETuMUPdj21psR_OfWgWn_fpnM0C7dp1ZRUUtaJIPnWwPv1l3GdjRBo7UwoVuFltNCibpijCbqsz9r7Yr8nk0i8A1BexeCx35HYbRdB6DdBiCBqt0EIImqf0TaRIjGrf9r7P-lciO9dzYNIny0q3v07YBg49CuwyMULXJOWUXLBPO0uBS_AMMuyaY
CitedBy_id crossref_primary_10_1111_all_16187
crossref_primary_10_1016_j_jaci_2020_01_047
crossref_primary_10_14309_ajg_0000000000002219
crossref_primary_10_1007_s11882_019_0835_9
crossref_primary_10_1007_s11894_022_00860_7
crossref_primary_10_1111_all_16381
crossref_primary_10_1080_23744235_2022_2057584
crossref_primary_10_1093_cvr_cvab285
crossref_primary_10_1111_aen_12480
crossref_primary_10_1073_pnas_2123212119
crossref_primary_10_1111_all_13873
crossref_primary_10_2147_ITT_S276872
crossref_primary_10_1016_j_jaci_2018_10_029
crossref_primary_10_1016_j_jaip_2024_06_035
crossref_primary_10_1016_j_aller_2019_07_004
crossref_primary_10_1111_all_14802
crossref_primary_10_1038_s41598_025_93031_3
crossref_primary_10_1016_j_jaip_2023_10_046
crossref_primary_10_1111_cea_13695
crossref_primary_10_1152_physrev_00041_2023
crossref_primary_10_1016_j_biopha_2023_115829
crossref_primary_10_1016_j_jaad_2023_04_054
crossref_primary_10_1016_j_athoracsur_2020_07_050
crossref_primary_10_1042_BCJ20200915
crossref_primary_10_1007_s40521_024_00371_y
crossref_primary_10_1111_pai_13854
crossref_primary_10_1007_s40267_023_01005_0
crossref_primary_10_1016_j_anai_2022_07_002
crossref_primary_10_1161_ATVBAHA_120_314735
crossref_primary_10_1053_j_jvca_2024_07_035
crossref_primary_10_1161_ATVBAHA_120_313609
crossref_primary_10_1161_ATVBAHA_120_313608
crossref_primary_10_1097_MOP_0000000000000955
crossref_primary_10_3389_falgy_2024_1488857
crossref_primary_10_1111_all_15426
crossref_primary_10_18632_aging_101894
crossref_primary_10_3389_falgy_2023_1270326
crossref_primary_10_3389_fcimb_2021_680264
crossref_primary_10_3389_fcvm_2021_791028
crossref_primary_10_4049_jimmunol_2100712
crossref_primary_10_1111_cea_13683
crossref_primary_10_1016_j_cgh_2022_12_035
crossref_primary_10_1161_ATVBAHA_119_312001
crossref_primary_10_3389_fcvm_2022_864602
crossref_primary_10_3389_falgy_2021_783279
crossref_primary_10_1111_all_15230
crossref_primary_10_3389_fimmu_2024_1335911
crossref_primary_10_1016_j_numecd_2024_103833
crossref_primary_10_3390_molecules28145452
crossref_primary_10_1016_j_anai_2019_11_024
crossref_primary_10_1016_j_anai_2019_03_021
crossref_primary_10_1111_all_16003
crossref_primary_10_1186_s12979_022_00316_6
crossref_primary_10_1080_1744666X_2025_2475984
crossref_primary_10_1002_chem_202500050
crossref_primary_10_1111_aen_12420
crossref_primary_10_3389_falgy_2025_1535103
crossref_primary_10_1007_s12016_024_08981_9
crossref_primary_10_1111_all_16529
crossref_primary_10_1097_ACI_0000000000000523
crossref_primary_10_1097_TP_0000000000003408
crossref_primary_10_3389_fped_2021_801753
crossref_primary_10_1016_j_anai_2024_01_029
crossref_primary_10_1016_j_biopha_2018_11_142
crossref_primary_10_1161_ATVBAHA_121_316878
crossref_primary_10_3389_fimmu_2019_01210
crossref_primary_10_1016_j_jaci_2020_02_012
crossref_primary_10_1016_j_jaci_2023_09_038
crossref_primary_10_1055_a_1870_7328
crossref_primary_10_1161_ATVBAHA_118_311999
crossref_primary_10_7759_cureus_24551
crossref_primary_10_1007_s40257_022_00696_x
crossref_primary_10_1016_j_jaip_2019_09_017
crossref_primary_10_1007_s12350_018_01506_w
crossref_primary_10_1016_j_jtcvs_2021_03_100
Cites_doi 10.1016/j.atherosclerosis.2016.05.045
10.1038/nm1601
10.1172/JCI46028
10.1126/science.117.3045.505
10.1016/j.jaci.2014.01.024
10.1056/NEJMoa074943
10.1161/CIRCRESAHA.117.306044
10.1371/journal.pone.0090222
10.1016/S0735-1097(01)01175-5
10.1007/s11882-017-0672-7
10.1016/S0368-1319(69)80071-2
10.1084/jem.160.5.1519
10.1016/j.alit.2015.10.001
10.1111/all.13156
10.1016/j.jaci.2008.10.052
10.1016/j.jaci.2011.02.019
10.1038/ni.2001
10.1371/journal.pone.0055566
10.1016/j.jim.2005.12.003
ContentType Journal Article
Copyright 2018 American Heart Association, Inc.
2018 American Heart Association, Inc. 2018
Copyright_xml – notice: 2018 American Heart Association, Inc.
– notice: 2018 American Heart Association, Inc. 2018
DBID AAYXX
CITATION
NPM
7X8
5PM
DOI 10.1161/ATVBAHA.118.311222
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1524-4636
EndPage 1669
ExternalDocumentID PMC6039405
29903734
10_1161_ATVBAHA_118_311222
00043605-201807000-00024
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: R37 AI020565
– fundername: NHLBI NIH HHS
  grantid: R01 HL107490
– fundername: NIAID NIH HHS
  grantid: R01 AI020565
– fundername: NHLBI NIH HHS
  grantid: K23 HL093118
– fundername: NHLBI NIH HHS
  grantid: P01 HL055798
– fundername: NHLBI NIH HHS
  grantid: R01 HL136098
– fundername: NHLBI NIH HHS
  grantid: P01 HL136275
– fundername: NIAID NIH HHS
  grantid: T32 AI007496
– fundername: NIAID NIH HHS
  grantid: K08 AI085190
GroupedDBID ---
.3C
.55
.GJ
.Z2
01R
0R~
1J1
23N
2WC
3O-
40H
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
71W
77Y
7O~
AAAAV
AAAXR
AAGIX
AAHPQ
AAIQE
AAMOA
AAMTA
AAQKA
AARTV
AASCR
AASOK
AAXQO
ABASU
ABBUW
ABDIG
ABJNI
ABPXF
ABQRW
ABVCZ
ABXVJ
ABZAD
ABZZY
ACCJW
ACDDN
ACEWG
ACGFS
ACGOD
ACILI
ACLDA
ACPRK
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADBBV
ADFPA
ADGGA
ADHPY
ADNKB
AE3
AE6
AEETU
AENEX
AFBFQ
AFDTB
AFFNX
AFUWQ
AGINI
AHJKT
AHMBA
AHOMT
AHQNM
AHRYX
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
AYCSE
BAWUL
BOYCO
BQLVK
BS7
C1A
C45
CS3
DIK
DIWNM
DUNZO
E.X
E3Z
EBS
EEVPB
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
FRP
FW0
GNXGY
GQDEL
GX1
H0~
H13
HLJTE
HZ~
IKREB
IKYAY
IN~
IPNFZ
J5H
JF9
JG8
JK3
JK8
K8S
KD2
KMI
KQ8
L-C
L7B
N9A
N~7
N~B
N~M
O9-
OAG
OAH
OB2
OCUKA
ODA
OL1
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P-K
P2P
PQQKQ
PZZ
RAH
RIG
RLZ
S4R
S4S
T8P
TEORI
TR2
TSPGW
V2I
VVN
W3M
W8F
WOQ
WOW
X3V
X3W
X7M
XXN
XYM
YFH
ZGI
ZZMQN
AAYXX
ADGHP
CITATION
ACIJW
AWKKM
NPM
OK1
OLW
RHF
7X8
ADKSD
ADSXY
5PM
ID FETCH-LOGICAL-c3624-7a233fff727584d8ef6e4ee6f619ba45e513df5f28e7c6c2540e94a3bce6586a3
ISSN 1079-5642
1524-4636
IngestDate Thu Aug 21 18:30:33 EDT 2025
Mon Sep 08 10:25:19 EDT 2025
Wed Feb 19 02:36:16 EST 2025
Tue Jul 01 02:22:00 EDT 2025
Thu Apr 24 23:02:52 EDT 2025
Fri May 16 03:42:33 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords atherosclerosis
galactosyl-(1-3)galactose
risk factors
immunoglobulin E
red meat
Language English
License 2018 American Heart Association, Inc.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c3624-7a233fff727584d8ef6e4ee6f619ba45e513df5f28e7c6c2540e94a3bce6586a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC6039405
PMID 29903734
PQID 2056398110
PQPubID 23479
PageCount 5
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6039405
proquest_miscellaneous_2056398110
pubmed_primary_29903734
crossref_primary_10_1161_ATVBAHA_118_311222
crossref_citationtrail_10_1161_ATVBAHA_118_311222
wolterskluwer_health_00043605-201807000-00024
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-July
PublicationDateYYYYMMDD 2018-07-01
PublicationDate_xml – month: 07
  year: 2018
  text: 2018-July
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Arteriosclerosis, thrombosis, and vascular biology
PublicationTitleAlternate Arterioscler Thromb Vasc Biol
PublicationYear 2018
Publisher American Heart Association, Inc
Lippincott Williams & Wilkins
Publisher_xml – name: American Heart Association, Inc
– name: Lippincott Williams & Wilkins
References e_1_3_5_17_2
Galili U (e_1_3_5_9_2) 2017
e_1_3_5_16_2
e_1_3_5_15_2
e_1_3_5_14_2
e_1_3_5_12_2
e_1_3_5_13_2
e_1_3_5_10_2
e_1_3_5_11_2
e_1_3_5_21_2
e_1_3_5_19_2
e_1_3_5_18_2
e_1_3_5_2_2
e_1_3_5_8_2
e_1_3_5_20_2
e_1_3_5_7_2
e_1_3_5_4_2
e_1_3_5_3_2
e_1_3_5_6_2
e_1_3_5_5_2
References_xml – ident: e_1_3_5_7_2
  doi: 10.1016/j.atherosclerosis.2016.05.045
– ident: e_1_3_5_5_2
  doi: 10.1038/nm1601
– ident: e_1_3_5_6_2
  doi: 10.1172/JCI46028
– ident: e_1_3_5_4_2
  doi: 10.1126/science.117.3045.505
– ident: e_1_3_5_14_2
  doi: 10.1016/j.jaci.2014.01.024
– ident: e_1_3_5_10_2
  doi: 10.1056/NEJMoa074943
– ident: e_1_3_5_19_2
  doi: 10.1161/CIRCRESAHA.117.306044
– ident: e_1_3_5_16_2
  doi: 10.1371/journal.pone.0090222
– ident: e_1_3_5_15_2
  doi: 10.1016/S0735-1097(01)01175-5
– ident: e_1_3_5_21_2
  doi: 10.1007/s11882-017-0672-7
– ident: e_1_3_5_3_2
  doi: 10.1016/S0368-1319(69)80071-2
– ident: e_1_3_5_8_2
  doi: 10.1084/jem.160.5.1519
– ident: e_1_3_5_13_2
  doi: 10.1016/j.alit.2015.10.001
– ident: e_1_3_5_17_2
  doi: 10.1111/all.13156
– ident: e_1_3_5_11_2
  doi: 10.1016/j.jaci.2008.10.052
– ident: e_1_3_5_12_2
  doi: 10.1016/j.jaci.2011.02.019
– ident: e_1_3_5_2_2
  doi: 10.1038/ni.2001
– volume-title: The Natural Anti-Gal Antibody as Foe Turned Friend in Medicine.
  year: 2017
  ident: e_1_3_5_9_2
– ident: e_1_3_5_18_2
  doi: 10.1371/journal.pone.0055566
– ident: e_1_3_5_20_2
  doi: 10.1016/j.jim.2005.12.003
SSID ssj0004220
Score 2.5102737
Snippet OBJECTIVE—Emerging evidence suggests a link between coronary artery disease and type 2 immunity. We sought to test the hypothesis that IgE sensitization to the...
Emerging evidence suggests a link between coronary artery disease and type 2 immunity. We sought to test the hypothesis that IgE sensitization to the mammalian...
Supplemental Digital Content is available in the text.
SourceID pubmedcentral
proquest
pubmed
crossref
wolterskluwer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1665
SubjectTerms Clinical and Population Studies
Title IgE to the Mammalian Oligosaccharide Galactose-α-1,3-Galactose Is Associated With Increased Atheroma Volume and Plaques With Unstable Characteristics—Brief Report
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00043605-201807000-00024
https://www.ncbi.nlm.nih.gov/pubmed/29903734
https://www.proquest.com/docview/2056398110
https://pubmed.ncbi.nlm.nih.gov/PMC6039405
Volume 38
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1djtMwELZ2FwkhIcTPAuVPRmKfiksTJ07y2FZF7aLyo22XfYucxGkr2gaRVmh54hBcgQNwEQ7BSRjHjpu2C2J5iWrHcWvNl5lv3JkxQs9olAS2m3LSTH25dcN8wh1BCfeAjLucJnFxnM_gNeuNnOMz92xv_7AStbRaRo34y4V5Jf8jVegDucos2UtI1kwKHfAZ5AtXkDBc_0nG_XG35I4DPp-rLYs3s-k4y3ks86mmCYCAz-SZOrkgR53uUdsioLs6lJjuej83QgL2-V5uzILWkMHq0GxJgpjNef20UGMquWDGpTVRQ0eSX8r0q85m6ecyisJpgzOeaqJfpcItGUw6zXJYE1hqVepAHtowj8qW_C4TKaurRVX2iXSumM5Fqw8aZmN7vDoXujTCpD40_SfxZHWuMx9NYk_92NyXyTJ6-_2kKFnxtlHdFLF8E0Bb6vGmFxCXqcJdDaF1u-0QWR-tqvypXwG5V9HkFlNnWGhWAM3gYovDpMVpDU_brV4Lmn6DAoW17bV9LWMKtsyuCYYs3DBmhXoOaPihmmMfXbE9r4g-ePWuUgTftlWRDb3GMheMWS92f8cm39pxonZjga9_zmScRv6hSNOokK3hTXRDe0m4pSB_C-2JxW10daDjQO6g74B8vMwwgBMb5OMt5OM18n_-INbzCuZxP8drzGMJZGwwj0vMY4V5DDjBGvNqaIl5vIX5X1-_FWjHCu2HaPSyO-z0iD5whMTA4xzicZvSNE2B0wMvT3yRMuEIwVJmBRF3XOFaNEnd1PaFF7PYBm9HBA6nUSyAyDNO76KDRbYQ9xH2hZ-CtvNcebaV4yZBSi3B4dHYjRzmRjVklWIJY12NXx4KMwv_DIcaqptnPqpaNH8d_bSUdggmQ_4PyBciW-WhDU4PDXwg_jV0T0nfzCfZKfWoU0PeBi7MAFmOfvPOYjopytKzJg3A_ashsoGgUCV0h0XQAWu6RL6vQDRURQvbeXCpVT1E19bv-yN0sPy0Eo_BLVhGT4qX5DcZOgtv
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=IgE+to+the+Mammalian+Oligosaccharide+Galactose-%CE%B1-1%2C3-Galactose+Is+Associated+With+Increased+Atheroma+Volume+and+Plaques+With+Unstable+Characteristics%E2%80%94Brief+Report&rft.jtitle=Arteriosclerosis%2C+thrombosis%2C+and+vascular+biology&rft.au=Wilson%2C+Jeffrey+M.&rft.au=Nguyen%2C+Anh+T.&rft.au=Schuyler%2C+Alexander+J.&rft.au=Commins%2C+Scott+P.&rft.date=2018-07-01&rft.issn=1079-5642&rft.eissn=1524-4636&rft.volume=38&rft.issue=7&rft.spage=1665&rft.epage=1669&rft_id=info:doi/10.1161%2FATVBAHA.118.311222&rft.externalDBID=n%2Fa&rft.externalDocID=10_1161_ATVBAHA_118_311222
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1079-5642&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1079-5642&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1079-5642&client=summon